|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0030946,
umls-concept:C0032659,
umls-concept:C0033105,
umls-concept:C0033607,
umls-concept:C0040833,
umls-concept:C0332157,
umls-concept:C0439849,
umls-concept:C0445223,
umls-concept:C0449774,
umls-concept:C0683598,
umls-concept:C1511253,
umls-concept:C1521798,
umls-concept:C1552599,
umls-concept:C1704787
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2008-10-8
|
|
pubmed:abstractText |
In recent years, several new drugs from the protease inhibitor (PI) class designed to treat HIV infection have become available and the use of ritonavir-boosting has increased in popularity. These changes might be expected to affect the prevalence and patterns of protease resistance in the population of patients who experience treatment failure.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1359-6535
|
|
pubmed:author |
pubmed-author:ChurchillDuncanD,
pubmed-author:DunnDavidD,
pubmed-author:FearnhillEstherE,
pubmed-author:GerettiAnna MariaAM,
pubmed-author:GreenHannahH,
pubmed-author:PhillipsAndrewA,
pubmed-author:PillayDeenanD,
pubmed-author:PozniakAntonA,
pubmed-author:SabinCarolineC,
pubmed-author:UK Collaborative Group on HIV Drug Resistance,
pubmed-author:UK Collaborative HIV Cohort Study
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
13
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
771-7
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:18839778-Cohort Studies,
pubmed-meshheading:18839778-Cross-Sectional Studies,
pubmed-meshheading:18839778-Databases, Factual,
pubmed-meshheading:18839778-Drug Resistance, Viral,
pubmed-meshheading:18839778-Genetic Testing,
pubmed-meshheading:18839778-Great Britain,
pubmed-meshheading:18839778-HIV,
pubmed-meshheading:18839778-HIV Infections,
pubmed-meshheading:18839778-HIV Protease,
pubmed-meshheading:18839778-HIV Protease Inhibitors,
pubmed-meshheading:18839778-Humans,
pubmed-meshheading:18839778-Mutation,
pubmed-meshheading:18839778-Prevalence,
pubmed-meshheading:18839778-Ritonavir,
pubmed-meshheading:18839778-Treatment Outcome
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Population trends in the prevalence and patterns of protease resistance related to exposure to unboosted and boosted protease inhibitors.
|
|
pubmed:affiliation |
MRC Clinical Trials Unit, London, UK.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study
|
